{"id":"https://openalex.org/W2163553489","doi":"https://doi.org/10.1039/c3np20126k","title":"From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes","display_name":"From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2163553489","doi":"https://doi.org/10.1039/c3np20126k","mag":"2163553489","pmid":"https://pubmed.ncbi.nlm.nih.gov/23575525","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3815659"},"language":"en","primary_location":{"id":"doi:10.1039/c3np20126k","doi":"https://doi.org/10.1039/c3np20126k","is_oa":false,"landing_page_url":"https://doi.org/10.1039/c3np20126k","pdf_url":null,"source":{"id":"https://openalex.org/S18855311","display_name":"Natural Product Reports","issn_l":"0265-0568","issn":["0265-0568","1460-4752"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-2","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Natural Product Reports","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3815659","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042895775","display_name":"Kyung Bo Kim","orcid":"https://orcid.org/0000-0003-4744-2466","observed_orcids":["https://orcid.org/0000-0003-4744-2466"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyung Bo Kim","raw_affiliation_strings":["Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016866989","display_name":"Craig M. Crews","orcid":"https://orcid.org/0000-0002-8456-2005","observed_orcids":["https://orcid.org/0000-0002-8456-2005"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Craig M. Crews","raw_affiliation_strings":["Departments of Molecular, Cellular & Developmental Biology; Chemistry; Pharmacology, Yale University, New Haven, CT, USA","Chemistry","Departments of Molecular, Cellular & Developmental Biology","Pharmacology, Yale University, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Molecular, Cellular & Developmental Biology; Chemistry; Pharmacology, Yale University, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Chemistry","institution_ids":[]},{"raw_affiliation_string":"Departments of Molecular, Cellular & Developmental Biology","institution_ids":[]},{"raw_affiliation_string":"Pharmacology, Yale University, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5016866989"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":null,"apc_paid":null,"fwci":5.3988,"has_fulltext":false,"cited_by_count":173,"citation_normalized_percentile":{"value":0.97272947,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"30","issue":"5","first_page":"600","last_page":"600"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.46630001068115234,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.46630001068115234,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.17299999296665192,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.09809999912977219,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epoxomicin","display_name":"epoxomicin","score":1.0},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.7820000052452087},{"id":"https://openalex.org/keywords/natural-product-drug-discovery","display_name":"natural product drug discovery","score":0.7620000243186951},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9269999861717224},{"id":"https://openalex.org/keywords/lead-optimization","display_name":"lead optimization","score":0.49300000071525574},{"id":"https://openalex.org/keywords/rational-drug-design","display_name":"rational drug design","score":0.6240000128746033},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.9300540685653687},{"id":"https://openalex.org/C2779396153","wikidata":"https://www.wikidata.org/wiki/Q901227","display_name":"Natural product","level":2,"score":0.7485966682434082},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.6149736046791077},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6148195862770081},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4282490611076355},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.4231044054031372},{"id":"https://openalex.org/C2776818590","wikidata":"https://www.wikidata.org/wiki/Q6980583","display_name":"Natural Product Research","level":5,"score":0.4116837978363037},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35344022512435913},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.342590868473053},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.2702234387397766},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26306381821632385},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.15998193621635437},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.14105337858200073},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.13715007901191711},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13093626499176025},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1039/c3np20126k","doi":"https://doi.org/10.1039/c3np20126k","is_oa":false,"landing_page_url":"https://doi.org/10.1039/c3np20126k","pdf_url":null,"source":{"id":"https://openalex.org/S18855311","display_name":"Natural Product Reports","issn_l":"0265-0568","issn":["0265-0568","1460-4752"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-2","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Natural Product Reports","raw_type":"journal-article"},{"id":"pmid:23575525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23575525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Natural product reports","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2967390","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3815659","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3815659","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3815659","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Nat Prod Rep","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2967390","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3815659","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1283409554","display_name":"Natural Product Model of Action Studies","funder_award_id":"R01GM062120","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G2149320613","display_name":null,"funder_award_id":"GM062120","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W44163030","https://openalex.org/W56897422","https://openalex.org/W1553908537","https://openalex.org/W1569049012","https://openalex.org/W1851733051","https://openalex.org/W1978726512","https://openalex.org/W1984944362","https://openalex.org/W1985275612","https://openalex.org/W1993357468","https://openalex.org/W1996091402","https://openalex.org/W2010228920","https://openalex.org/W2012762978","https://openalex.org/W2017072183","https://openalex.org/W2020431842","https://openalex.org/W2066875565","https://openalex.org/W2067653691","https://openalex.org/W2083365324","https://openalex.org/W2089311432","https://openalex.org/W2090310344","https://openalex.org/W2106578289","https://openalex.org/W2107257265","https://openalex.org/W2111139603","https://openalex.org/W2130338082","https://openalex.org/W2142075224","https://openalex.org/W2143794875","https://openalex.org/W2147644408","https://openalex.org/W2154343997","https://openalex.org/W2159831275","https://openalex.org/W2166987747","https://openalex.org/W2315267959","https://openalex.org/W4235721540"],"related_works":["https://openalex.org/W2328407420","https://openalex.org/W2066875565","https://openalex.org/W2008599415","https://openalex.org/W7151922239","https://openalex.org/W1988058882","https://openalex.org/W362871004","https://openalex.org/W1856445251","https://openalex.org/W2316050582","https://openalex.org/W2318882471","https://openalex.org/W7037474818"],"abstract_inverted_index":{"The":[0],"initial":[1,51],"enthusiasm":[2],"following":[3],"the":[4,17,27,90,99,112,119,137,155,160,167,173,181],"discovery":[5,52,161],"of":[6,30,46,101,116,130,162,170],"a":[7,34,57,96,102],"pharmacologically":[8],"active":[9,142],"natural":[10,60,143,186],"product":[11,144],"is":[12],"often":[13,150],"fleeting":[14],"due":[15,68],"to":[16,69,85],"poor":[18],"prospects":[19,138],"for":[20,37,66,89,98,124,139,183],"its":[21,50,70,79],"ultimate":[22],"clinical":[23],"application.":[24],"Despite":[25,78],"this,":[26],"ever-changing":[28],"landscape":[29],"modern":[31],"biology":[32],"has":[33],"constant":[35],"need":[36],"molecular":[38],"probes":[39],"that":[40,157],"can":[41],"aid":[42],"in":[43,172,185],"our":[44],"understanding":[45,154],"biological":[47],"processes.":[48],"After":[49],"by":[53,153],"Bristol-Myers":[54],"Squibb":[55],"as":[56,95],"microbial":[58],"anti-tumor":[59],"product,":[61],"epoxomicin":[62,163],"was":[63,83],"deemed":[64],"unfit":[65],"development":[67],"peptide":[71],"structure":[72],"and":[73,134,164],"potentially":[74],"labile":[75],"epoxyketone":[76,105],"pharmacophore.":[77],"drawbacks,":[80],"epoxomicin's":[81],"pharmacophore":[82],"found":[84],"provide":[86],"unprecedented":[87],"selectivity":[88],"proteasome.":[91],"Epoxomicin":[92],"also":[93],"served":[94],"scaffold":[97],"generation":[100],"synthetic":[103],"tetrapeptide":[104],"with":[106,159,166],"improved":[107],"activity,":[108],"YU-101,":[109],"which":[110],"became":[111],"parent":[113],"lead":[114],"compound":[115],"carfilzomib":[117,171],"(Kyprolis\u2122),":[118],"recently":[120],"approved":[121,147],"therapeutic":[122],"agent":[123],"multiple":[125],"myeloma.":[126],"In":[127],"this":[128],"era":[129],"rational":[131],"drug":[132,188],"design":[133],"high-throughput":[135],"screening,":[136],"turning":[140],"an":[141,146],"into":[145,180],"therapy":[148],"are":[149],"slim.":[151],"However,":[152],"journey":[156],"began":[158],"ended":[165],"successful":[168],"use":[169],"clinic,":[174],"we":[175],"may":[176],"find":[177],"new":[178],"insights":[179],"keys":[182],"success":[184],"product-based":[187],"discovery.":[189]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":20},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}